A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention

AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).

NCT03317002 ·Status: COMPLETED ·Phase: PHASE2

Platelet Drug Trial in Coronary Disease Progression

NCT00000496 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy

NCT01852162 ·Status: COMPLETED ·Phase: NA

ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

NCT00296218 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Apixaban in Recent Acute Coronary Syndrome

NCT00313300 ·Status: COMPLETED ·Phase: PHASE2

Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

NCT00240643 ·Status: COMPLETED ·Phase: PHASE2

Platelet Function in Patients With an Acute Coronary Syndrome

NCT01992484 ·Status: UNKNOWN

A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

NCT03698513 ·Status: COMPLETED ·Phase: PHASE1

Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome

NCT06254391 ·Status: RECRUITING ·Phase: PHASE2

Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy

NCT02921126 ·Status: COMPLETED

Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.

NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3

Study to Investigate Safety and Tolerability of a Single Dose of AZD6482

NCT00688714 ·Status: COMPLETED ·Phase: PHASE1

Prospective Real-world Registry Describing Treatment Regimens

NCT03942913 ·Status: UNKNOWN

Women With Chest Pain and Normal Coronary Arteries Study

NCT00743197 ·Status: TERMINATED ·Phase: NA

Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

NCT01938248 ·Status: COMPLETED ·Phase: PHASE4

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

NCT07000357 ·Status: RECRUITING ·Phase: PHASE3

Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy

NCT02049762 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718

NCT04087187 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

NCT02293395 ·Status: COMPLETED ·Phase: PHASE2

Platelet-Inhibitor Drug Trial in Coronary Angioplasty

NCT00000510 ·Status: COMPLETED ·Phase: PHASE3

Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers

NCT02618837 ·Status: UNKNOWN ·Phase: PHASE4

Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)

NCT00684203 ·Status: COMPLETED ·Phase: PHASE2

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)

NCT00249795 ·Status: COMPLETED ·Phase: PHASE3

Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients

NCT01465503 ·Status: COMPLETED ·Phase: PHASE3

Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI

NCT00735280 ·Status: COMPLETED ·Phase: PHASE4